Anderson Fabry Disease

8 clinical trials · Condition

Record	Firm	Date
Fabry Disease in High-risk Patients With Left Ventricular Hypertrophy: Prevalence and Implementation of a Clinical Score (NCT04943991)	Wuerzburg University Hospital	2021-07-01
Treatment-related Benefit and Satisfaction in Fabry Patients. Insight in Patients Expectations and Preferences (NCT04043273)	Amicus Therapeutics France SAS	2019-04-04
Multimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Patients with Non-ischemic Cardiomyopathies and Arrhythmogenic-inflammatory Phenotypes: a Multicenter, Observational, Retrospective and Prospective Registry Study. (NCT06607471)	Scientific Institute San Raffaele	2018-01-30
Follow-up of Myocardial T1 Relaxation Time in Patients With Anderson Fabry Disease (NCT02956954)	University Hospital, Rouen	2017-03-25
The Efficacy and Safety of Switch Between Agalsidase Beta to Agalsidase Alfa for Enzyme Replacement in Patients With Anderson-Fabry Disease (NCT01268241)	CENTOGENE GmbH Rostock	2010-12-01

Every clearance here is in the API, with alerts when new ones post.